| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Natural Killer T-Cells | 16 | 2020 | 318 | 2.880 |
Why?
|
| Mycobacterium | 25 | 2019 | 252 | 1.850 |
Why?
|
| Leprosy | 11 | 2014 | 125 | 1.350 |
Why?
|
| Antigens, Bacterial | 18 | 2014 | 1150 | 1.260 |
Why?
|
| Lymphocyte Activation | 10 | 2019 | 5496 | 1.080 |
Why?
|
| Mycobacterium leprae | 13 | 2014 | 95 | 1.030 |
Why?
|
| Hypersensitivity | 3 | 2024 | 1173 | 0.990 |
Why?
|
| Lymphoid Enhancer-Binding Factor 1 | 1 | 2024 | 85 | 0.890 |
Why?
|
| T Cell Transcription Factor 1 | 1 | 2024 | 72 | 0.880 |
Why?
|
| Skin Tests | 3 | 2014 | 639 | 0.860 |
Why?
|
| Hepatocyte Nuclear Factor 1-alpha | 1 | 2024 | 174 | 0.850 |
Why?
|
| Cross Infection | 7 | 2015 | 1426 | 0.820 |
Why?
|
| Multipotent Stem Cells | 1 | 2024 | 200 | 0.820 |
Why?
|
| Lipopolysaccharides | 22 | 2018 | 2215 | 0.810 |
Why?
|
| Mycobacterium tuberculosis | 29 | 2012 | 1929 | 0.800 |
Why?
|
| Glycolipids | 11 | 2020 | 206 | 0.790 |
Why?
|
| Galactans | 10 | 2002 | 31 | 0.780 |
Why?
|
| Antigens, CD1d | 4 | 2020 | 225 | 0.710 |
Why?
|
| Hypersensitivity, Immediate | 1 | 2022 | 349 | 0.660 |
Why?
|
| Personnel, Hospital | 1 | 2021 | 285 | 0.660 |
Why?
|
| Food Hypersensitivity | 3 | 2022 | 733 | 0.660 |
Why?
|
| Receptors, Antigen, T-Cell, alpha-beta | 4 | 2017 | 808 | 0.650 |
Why?
|
| Galactosylceramides | 2 | 2017 | 90 | 0.640 |
Why?
|
| Th2 Cells | 2 | 2024 | 1079 | 0.630 |
Why?
|
| Mycolic Acids | 12 | 2004 | 54 | 0.600 |
Why?
|
| Caffeine | 1 | 2022 | 702 | 0.600 |
Why?
|
| Mycobacterium smegmatis | 10 | 2006 | 126 | 0.580 |
Why?
|
| Antigen Presentation | 6 | 2016 | 1251 | 0.520 |
Why?
|
| Glucosylceramides | 1 | 2014 | 27 | 0.480 |
Why?
|
| Receptors, Antigen, T-Cell | 7 | 2016 | 2568 | 0.460 |
Why?
|
| Neglected Diseases | 1 | 2014 | 67 | 0.440 |
Why?
|
| Cell Wall | 16 | 2006 | 421 | 0.430 |
Why?
|
| Trehalose | 6 | 2019 | 88 | 0.420 |
Why?
|
| Drug Hypersensitivity | 4 | 2020 | 923 | 0.410 |
Why?
|
| Bacterial Infections | 2 | 2011 | 1397 | 0.400 |
Why?
|
| Phenylthiourea | 2 | 2003 | 10 | 0.390 |
Why?
|
| Antitubercular Agents | 8 | 2003 | 1391 | 0.380 |
Why?
|
| T-Lymphocyte Subsets | 7 | 2019 | 1813 | 0.380 |
Why?
|
| Glycosphingolipids | 1 | 2011 | 73 | 0.370 |
Why?
|
| Vaccination | 3 | 2023 | 3431 | 0.370 |
Why?
|
| Lymphocytes | 1 | 2019 | 2611 | 0.360 |
Why?
|
| Desensitization, Immunologic | 3 | 2020 | 559 | 0.350 |
Why?
|
| Chromatography, Thin Layer | 12 | 2014 | 212 | 0.340 |
Why?
|
| Infection Control | 4 | 2011 | 985 | 0.340 |
Why?
|
| Equipment Contamination | 1 | 2011 | 183 | 0.330 |
Why?
|
| Enterococcus | 3 | 1999 | 159 | 0.320 |
Why?
|
| Sphingolipids | 2 | 2022 | 178 | 0.320 |
Why?
|
| Bacteremia | 3 | 2011 | 985 | 0.310 |
Why?
|
| Philadelphia | 5 | 2022 | 271 | 0.310 |
Why?
|
| Spectrometry, Mass, Fast Atom Bombardment | 10 | 2002 | 34 | 0.290 |
Why?
|
| Catheters | 1 | 2011 | 427 | 0.290 |
Why?
|
| Catheter-Related Infections | 1 | 2011 | 275 | 0.290 |
Why?
|
| Carbohydrate Sequence | 13 | 2007 | 411 | 0.290 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2021 | 3231 | 0.290 |
Why?
|
| Gram-Positive Bacterial Infections | 3 | 1999 | 342 | 0.290 |
Why?
|
| Cell Proliferation | 7 | 2024 | 10478 | 0.280 |
Why?
|
| Autoantigens | 1 | 2011 | 891 | 0.280 |
Why?
|
| Transcription, Genetic | 6 | 2015 | 7599 | 0.280 |
Why?
|
| Vancomycin | 3 | 1999 | 505 | 0.280 |
Why?
|
| Immunologic Memory | 2 | 2013 | 1374 | 0.280 |
Why?
|
| Immune Tolerance | 3 | 2005 | 2324 | 0.270 |
Why?
|
| Immunity, Innate | 3 | 2019 | 3078 | 0.260 |
Why?
|
| Neuraminidase | 1 | 2005 | 195 | 0.250 |
Why?
|
| Molecular Sequence Data | 31 | 2007 | 17626 | 0.250 |
Why?
|
| Carbohydrate Conformation | 10 | 1997 | 206 | 0.240 |
Why?
|
| Comparative Effectiveness Research | 1 | 2010 | 713 | 0.240 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 7 | 2018 | 352 | 0.240 |
Why?
|
| Drug Resistance, Multiple, Bacterial | 1 | 2009 | 590 | 0.240 |
Why?
|
| Patient Care | 1 | 2010 | 629 | 0.240 |
Why?
|
| Safety Management | 1 | 2010 | 765 | 0.240 |
Why?
|
| Cell Degranulation | 2 | 2022 | 277 | 0.230 |
Why?
|
| Vaccines | 2 | 2023 | 842 | 0.230 |
Why?
|
| Phosphatidylinositols | 4 | 2002 | 280 | 0.230 |
Why?
|
| Polysaccharides, Bacterial | 3 | 1997 | 582 | 0.230 |
Why?
|
| Ethambutol | 4 | 1997 | 59 | 0.230 |
Why?
|
| Health Facilities | 1 | 2009 | 577 | 0.230 |
Why?
|
| Mice | 33 | 2024 | 82017 | 0.220 |
Why?
|
| Antigens, CD1 | 5 | 2012 | 434 | 0.220 |
Why?
|
| CD8-Positive T-Lymphocytes | 4 | 2019 | 4646 | 0.220 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2006 | 484 | 0.220 |
Why?
|
| Cyclins | 1 | 2006 | 606 | 0.220 |
Why?
|
| Animals | 44 | 2024 | 169337 | 0.220 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 2006 | 501 | 0.220 |
Why?
|
| Fatty Acid Desaturases | 1 | 2003 | 102 | 0.220 |
Why?
|
| Clonal Anergy | 2 | 2003 | 169 | 0.210 |
Why?
|
| Hospitals | 2 | 2021 | 3906 | 0.210 |
Why?
|
| Milk | 2 | 2017 | 443 | 0.210 |
Why?
|
| T-Lymphocytes | 9 | 2013 | 10267 | 0.210 |
Why?
|
| CD4-Positive T-Lymphocytes | 7 | 2014 | 4411 | 0.210 |
Why?
|
| Linoleic Acid | 1 | 2024 | 159 | 0.210 |
Why?
|
| Drug Resistance, Microbial | 6 | 1999 | 830 | 0.210 |
Why?
|
| Bacillaceae Infections | 1 | 2011 | 8 | 0.200 |
Why?
|
| Tuberculosis | 8 | 2012 | 2029 | 0.200 |
Why?
|
| Receptors, Neuropeptide | 1 | 2022 | 106 | 0.200 |
Why?
|
| Antibodies, Monoclonal | 5 | 2018 | 9261 | 0.200 |
Why?
|
| Bacillus cereus | 1 | 2011 | 36 | 0.200 |
Why?
|
| Receptor, Platelet-Derived Growth Factor alpha | 1 | 2023 | 368 | 0.190 |
Why?
|
| Cell Differentiation | 6 | 2024 | 11668 | 0.180 |
Why?
|
| Intramolecular Transferases | 1 | 2000 | 14 | 0.180 |
Why?
|
| Humans | 79 | 2024 | 768393 | 0.180 |
Why?
|
| Polyisoprenyl Phosphates | 1 | 2000 | 38 | 0.180 |
Why?
|
| Receptors, Death Domain | 1 | 2020 | 31 | 0.180 |
Why?
|
| Bacterial Proteins | 12 | 2006 | 3838 | 0.170 |
Why?
|
| Allergens | 3 | 2022 | 1441 | 0.170 |
Why?
|
| Anti-Bacterial Agents | 7 | 2011 | 7463 | 0.170 |
Why?
|
| Tuberculosis, Pulmonary | 3 | 2018 | 846 | 0.170 |
Why?
|
| Glycopeptides | 3 | 2000 | 225 | 0.160 |
Why?
|
| Thiourea | 1 | 1999 | 68 | 0.160 |
Why?
|
| Chloramphenicol | 1 | 1998 | 67 | 0.160 |
Why?
|
| Blood | 1 | 2011 | 597 | 0.160 |
Why?
|
| Isoniazid | 2 | 1999 | 288 | 0.160 |
Why?
|
| Macrophages, Alveolar | 2 | 2019 | 415 | 0.160 |
Why?
|
| Pentosyltransferases | 5 | 1998 | 62 | 0.150 |
Why?
|
| Receptors, Purinergic P2 | 1 | 2019 | 152 | 0.150 |
Why?
|
| Spectrometry, Mass, Electrospray Ionization | 3 | 2017 | 267 | 0.150 |
Why?
|
| Leukotrienes | 1 | 2019 | 232 | 0.150 |
Why?
|
| GTP-Binding Proteins | 1 | 2022 | 947 | 0.150 |
Why?
|
| Kruppel-Like Transcription Factors | 3 | 2017 | 507 | 0.150 |
Why?
|
| Milk, Human | 1 | 2022 | 489 | 0.150 |
Why?
|
| Interferon-gamma | 9 | 2012 | 3164 | 0.150 |
Why?
|
| Biological Assay | 2 | 2019 | 627 | 0.150 |
Why?
|
| Mycobacteriophages | 2 | 1996 | 19 | 0.150 |
Why?
|
| Virulence Factors | 1 | 2011 | 502 | 0.150 |
Why?
|
| Mannose | 3 | 2012 | 120 | 0.150 |
Why?
|
| Sequence Homology, Amino Acid | 10 | 2006 | 2750 | 0.140 |
Why?
|
| Cells, Cultured | 9 | 2024 | 19022 | 0.140 |
Why?
|
| Basophils | 1 | 2020 | 407 | 0.140 |
Why?
|
| Skin Diseases, Bacterial | 2 | 1995 | 65 | 0.140 |
Why?
|
| Medicare | 2 | 2017 | 6881 | 0.140 |
Why?
|
| Salmonella typhi | 1 | 2019 | 200 | 0.140 |
Why?
|
| Mannosyltransferases | 3 | 2002 | 23 | 0.140 |
Why?
|
| Lymphedema | 1 | 2023 | 527 | 0.140 |
Why?
|
| Biological Specimen Banks | 1 | 2022 | 784 | 0.140 |
Why?
|
| Gene Expression Regulation | 6 | 2014 | 11918 | 0.140 |
Why?
|
| Cloning, Molecular | 8 | 2003 | 4168 | 0.140 |
Why?
|
| T-Lymphocytes, Regulatory | 3 | 2024 | 3112 | 0.140 |
Why?
|
| Promoter Regions, Genetic | 4 | 2006 | 5801 | 0.130 |
Why?
|
| Hospitalization | 2 | 2021 | 10844 | 0.130 |
Why?
|
| Cytotoxicity, Immunologic | 3 | 2017 | 1355 | 0.130 |
Why?
|
| Oligosaccharides | 3 | 1996 | 406 | 0.130 |
Why?
|
| Macrophages | 7 | 2024 | 5796 | 0.130 |
Why?
|
| Phospholipids | 2 | 2019 | 783 | 0.130 |
Why?
|
| Cluster Analysis | 4 | 2014 | 2728 | 0.130 |
Why?
|
| Anti-Infective Agents, Urinary | 1 | 1995 | 28 | 0.130 |
Why?
|
| Sugar Alcohols | 1 | 1995 | 18 | 0.120 |
Why?
|
| Amino Acid Sequence | 16 | 2006 | 13423 | 0.120 |
Why?
|
| Glycolates | 1 | 1995 | 41 | 0.120 |
Why?
|
| Mast Cells | 1 | 2022 | 1407 | 0.120 |
Why?
|
| Quality of Health Care | 1 | 2010 | 4339 | 0.120 |
Why?
|
| Amoeba | 1 | 2014 | 20 | 0.120 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2022 | 1248 | 0.120 |
Why?
|
| Cytokines | 3 | 2024 | 7445 | 0.120 |
Why?
|
| Magnetic Resonance Spectroscopy | 10 | 1997 | 3781 | 0.120 |
Why?
|
| Armadillos | 1 | 2014 | 7 | 0.120 |
Why?
|
| Cattle Diseases | 1 | 1994 | 50 | 0.120 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 4 | 2018 | 3813 | 0.120 |
Why?
|
| Cell Membrane | 6 | 2019 | 3663 | 0.120 |
Why?
|
| Leukocytes, Mononuclear | 3 | 2019 | 1855 | 0.120 |
Why?
|
| B-Lymphocytes | 2 | 2017 | 4785 | 0.120 |
Why?
|
| Cell Line | 9 | 2014 | 15597 | 0.120 |
Why?
|
| Dendritic Cells | 6 | 2020 | 2749 | 0.120 |
Why?
|
| Interleukin-1beta | 1 | 2020 | 1020 | 0.110 |
Why?
|
| Signal Transduction | 7 | 2020 | 23631 | 0.110 |
Why?
|
| Leprosy, Lepromatous | 2 | 2011 | 23 | 0.110 |
Why?
|
| Immunophenotyping | 1 | 2019 | 1866 | 0.110 |
Why?
|
| Drug Stability | 1 | 2014 | 291 | 0.110 |
Why?
|
| Hospital Administration | 2 | 2010 | 353 | 0.110 |
Why?
|
| Pneumonia, Pneumocystis | 1 | 1995 | 242 | 0.110 |
Why?
|
| Glucosylceramidase | 1 | 2014 | 125 | 0.110 |
Why?
|
| Lectins, C-Type | 4 | 2019 | 591 | 0.110 |
Why?
|
| Flow Cytometry | 4 | 2014 | 5900 | 0.110 |
Why?
|
| Guinea Pigs | 2 | 2014 | 1309 | 0.110 |
Why?
|
| Fatty Acids | 6 | 2004 | 1815 | 0.110 |
Why?
|
| Globosides | 1 | 2013 | 11 | 0.110 |
Why?
|
| Health Planning | 1 | 1995 | 232 | 0.110 |
Why?
|
| Trihexosylceramides | 1 | 2013 | 29 | 0.110 |
Why?
|
| Molecular Structure | 6 | 2000 | 1884 | 0.110 |
Why?
|
| Mycobacterium avium | 2 | 2007 | 29 | 0.110 |
Why?
|
| Metabolomics | 1 | 2022 | 1674 | 0.110 |
Why?
|
| Bacteriological Techniques | 1 | 2014 | 277 | 0.100 |
Why?
|
| Mass Spectrometry | 5 | 2014 | 2201 | 0.100 |
Why?
|
| Female | 27 | 2023 | 397089 | 0.100 |
Why?
|
| Social Class | 1 | 2021 | 2009 | 0.100 |
Why?
|
| Receptor, erbB-2 | 2 | 2000 | 2588 | 0.100 |
Why?
|
| Pharmaceutical Preparations | 1 | 2020 | 1088 | 0.100 |
Why?
|
| Drugs, Investigational | 1 | 2014 | 213 | 0.100 |
Why?
|
| Pneumonia | 1 | 2024 | 2163 | 0.100 |
Why?
|
| Cattle | 2 | 2014 | 3826 | 0.100 |
Why?
|
| Histocompatibility Antigens Class II | 2 | 2007 | 1438 | 0.100 |
Why?
|
| Mice, Inbred Strains | 1 | 2014 | 1769 | 0.100 |
Why?
|
| Nurses | 1 | 2021 | 2494 | 0.100 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2017 | 749 | 0.100 |
Why?
|
| Virulence Factors, Bordetella | 1 | 1991 | 154 | 0.090 |
Why?
|
| Pertussis Toxin | 1 | 1991 | 176 | 0.090 |
Why?
|
| Lymphoma, T-Cell | 1 | 2014 | 303 | 0.090 |
Why?
|
| Mice, Inbred C57BL | 10 | 2020 | 22355 | 0.090 |
Why?
|
| Male | 26 | 2023 | 364902 | 0.090 |
Why?
|
| Antigens, Differentiation, T-Lymphocyte | 3 | 2013 | 896 | 0.090 |
Why?
|
| Serum | 1 | 2011 | 207 | 0.090 |
Why?
|
| Ethionamide | 2 | 2000 | 11 | 0.090 |
Why?
|
| Antigens, CD | 4 | 2013 | 4031 | 0.090 |
Why?
|
| Antibiotic Prophylaxis | 1 | 1995 | 640 | 0.090 |
Why?
|
| Lymphoid Tissue | 1 | 2011 | 446 | 0.090 |
Why?
|
| Tissue Distribution | 1 | 2014 | 2299 | 0.090 |
Why?
|
| Information Management | 1 | 2010 | 100 | 0.090 |
Why?
|
| Nerve Tissue Proteins | 1 | 2022 | 4414 | 0.080 |
Why?
|
| Borderline Personality Disorder | 1 | 2017 | 767 | 0.080 |
Why?
|
| Subcellular Fractions | 2 | 2002 | 527 | 0.080 |
Why?
|
| Emergency Medical Services | 1 | 2021 | 1946 | 0.080 |
Why?
|
| Antigen-Antibody Complex | 1 | 1991 | 513 | 0.080 |
Why?
|
| Fatty Acids, Unsaturated | 2 | 2011 | 542 | 0.080 |
Why?
|
| Education, Medical, Graduate | 2 | 2015 | 2412 | 0.080 |
Why?
|
| Transferases (Other Substituted Phosphate Groups) | 2 | 2019 | 36 | 0.080 |
Why?
|
| Quantitative Trait Loci | 2 | 2014 | 2127 | 0.080 |
Why?
|
| Mice, Knockout | 5 | 2014 | 14481 | 0.080 |
Why?
|
| Galactosyltransferases | 2 | 2001 | 284 | 0.080 |
Why?
|
| Mannans | 2 | 2007 | 58 | 0.080 |
Why?
|
| Interleukin-2 | 4 | 2014 | 1894 | 0.080 |
Why?
|
| Patient Isolation | 1 | 2009 | 100 | 0.080 |
Why?
|
| Pneumonia, Aspiration | 1 | 2009 | 145 | 0.080 |
Why?
|
| Hospital Costs | 1 | 1995 | 959 | 0.080 |
Why?
|
| Program Development | 1 | 2015 | 1298 | 0.080 |
Why?
|
| Mice, Inbred BALB C | 2 | 2011 | 6234 | 0.080 |
Why?
|
| Immunity | 1 | 2014 | 1003 | 0.080 |
Why?
|
| Antigens, Differentiation | 1 | 1991 | 921 | 0.080 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 1995 | 1795 | 0.080 |
Why?
|
| Mycobacterium bovis | 3 | 2003 | 148 | 0.080 |
Why?
|
| Antibody Specificity | 2 | 2018 | 1065 | 0.070 |
Why?
|
| Species Specificity | 3 | 2013 | 2417 | 0.070 |
Why?
|
| Cell-Free System | 3 | 2003 | 340 | 0.070 |
Why?
|
| Chemokine CXCL12 | 1 | 2010 | 457 | 0.070 |
Why?
|
| Technology Assessment, Biomedical | 1 | 2010 | 309 | 0.070 |
Why?
|
| Immune System | 1 | 2013 | 801 | 0.070 |
Why?
|
| Receptors, Fc | 1 | 1991 | 538 | 0.070 |
Why?
|
| DNA, Bacterial | 5 | 2009 | 1479 | 0.070 |
Why?
|
| Acyltransferases | 2 | 2001 | 306 | 0.070 |
Why?
|
| Thymus Gland | 1 | 2012 | 1266 | 0.070 |
Why?
|
| Immunoprecipitation | 2 | 2010 | 874 | 0.070 |
Why?
|
| Electronic Health Records | 2 | 2022 | 4875 | 0.070 |
Why?
|
| Lectins | 2 | 2006 | 490 | 0.070 |
Why?
|
| Carbon Radioisotopes | 3 | 1998 | 567 | 0.070 |
Why?
|
| Blotting, Western | 2 | 2006 | 5037 | 0.070 |
Why?
|
| Pneumonia, Ventilator-Associated | 1 | 2011 | 278 | 0.070 |
Why?
|
| Models, Chemical | 3 | 2007 | 611 | 0.070 |
Why?
|
| Adult | 19 | 2021 | 223640 | 0.070 |
Why?
|
| Chemotaxis | 1 | 2010 | 600 | 0.070 |
Why?
|
| Middle Aged | 17 | 2021 | 223491 | 0.070 |
Why?
|
| Antibodies, Monoclonal, Murine-Derived | 1 | 2009 | 695 | 0.070 |
Why?
|
| Peptidoglycan | 3 | 2007 | 246 | 0.070 |
Why?
|
| Adhesins, Bacterial | 1 | 2006 | 118 | 0.070 |
Why?
|
| Genetic Variation | 3 | 2014 | 6606 | 0.070 |
Why?
|
| Immunologic Deficiency Syndromes | 2 | 2007 | 549 | 0.070 |
Why?
|
| Polysaccharides | 3 | 1997 | 1024 | 0.070 |
Why?
|
| Interleukin-4 | 2 | 2024 | 1157 | 0.070 |
Why?
|
| Celiac Disease | 1 | 2014 | 820 | 0.070 |
Why?
|
| Cyclin D2 | 1 | 2006 | 98 | 0.070 |
Why?
|
| Child, Preschool | 5 | 2022 | 42650 | 0.070 |
Why?
|
| Tuberculin Test | 1 | 2006 | 205 | 0.060 |
Why?
|
| Chromatography, Gas | 2 | 2003 | 150 | 0.060 |
Why?
|
| Pennsylvania | 3 | 2015 | 615 | 0.060 |
Why?
|
| Safety | 1 | 2010 | 1159 | 0.060 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2006 | 293 | 0.060 |
Why?
|
| Immunologic Tests | 1 | 2006 | 104 | 0.060 |
Why?
|
| Proteolipids | 1 | 2005 | 112 | 0.060 |
Why?
|
| Cell Communication | 1 | 2013 | 1660 | 0.060 |
Why?
|
| Advisory Committees | 1 | 2010 | 797 | 0.060 |
Why?
|
| Acylation | 3 | 1994 | 98 | 0.060 |
Why?
|
| Infant | 3 | 2022 | 36510 | 0.060 |
Why?
|
| Bacterial Typing Techniques | 1 | 2006 | 263 | 0.060 |
Why?
|
| Bacterial Adhesion | 1 | 2006 | 305 | 0.060 |
Why?
|
| Toll-Like Receptor 2 | 1 | 2007 | 348 | 0.060 |
Why?
|
| Hospitals, University | 2 | 1999 | 569 | 0.060 |
Why?
|
| Costs and Cost Analysis | 1 | 2011 | 1669 | 0.060 |
Why?
|
| Guanosine Diphosphate Mannose | 3 | 2002 | 4 | 0.060 |
Why?
|
| Mice, Inbred CBA | 1 | 2005 | 438 | 0.060 |
Why?
|
| Phosphotyrosine | 1 | 2005 | 458 | 0.060 |
Why?
|
| Disease Notification | 1 | 2005 | 95 | 0.060 |
Why?
|
| Leukocytes | 1 | 2013 | 2030 | 0.060 |
Why?
|
| Microbial Sensitivity Tests | 4 | 2011 | 1961 | 0.060 |
Why?
|
| Mannosides | 2 | 2001 | 7 | 0.060 |
Why?
|
| Cell Transformation, Viral | 1 | 2006 | 530 | 0.060 |
Why?
|
| Carbazoles | 1 | 2006 | 221 | 0.060 |
Why?
|
| Urinary Tract Infections | 1 | 2011 | 806 | 0.060 |
Why?
|
| Isoquinolines | 1 | 2006 | 354 | 0.060 |
Why?
|
| Genes, Bacterial | 2 | 1999 | 1076 | 0.060 |
Why?
|
| Professional Competence | 1 | 2007 | 430 | 0.060 |
Why?
|
| Computational Biology | 2 | 2014 | 3543 | 0.060 |
Why?
|
| Valerates | 1 | 2004 | 20 | 0.060 |
Why?
|
| Metabolome | 1 | 2011 | 1008 | 0.060 |
Why?
|
| Mandatory Reporting | 1 | 2005 | 123 | 0.060 |
Why?
|
| Mice, Transgenic | 3 | 2009 | 9562 | 0.060 |
Why?
|
| Mannose-Binding Lectins | 1 | 2004 | 99 | 0.060 |
Why?
|
| Actins | 1 | 1991 | 2059 | 0.060 |
Why?
|
| Stearic Acids | 1 | 2003 | 56 | 0.060 |
Why?
|
| Immunoglobulin E | 2 | 2020 | 1506 | 0.050 |
Why?
|
| Autoimmunity | 1 | 2011 | 1360 | 0.050 |
Why?
|
| Oligopeptides | 2 | 2000 | 1194 | 0.050 |
Why?
|
| Physicians | 1 | 2021 | 4614 | 0.050 |
Why?
|
| Health Care Surveys | 1 | 2011 | 2437 | 0.050 |
Why?
|
| Chromatography, Gel | 3 | 2002 | 637 | 0.050 |
Why?
|
| Oleic Acid | 1 | 2003 | 92 | 0.050 |
Why?
|
| Enzyme Inhibitors | 3 | 2006 | 3722 | 0.050 |
Why?
|
| Langerhans Cells | 1 | 2004 | 169 | 0.050 |
Why?
|
| Nucleic Acid Amplification Techniques | 1 | 2006 | 339 | 0.050 |
Why?
|
| Stearoyl-CoA Desaturase | 1 | 2003 | 85 | 0.050 |
Why?
|
| Genetic Diseases, X-Linked | 1 | 2007 | 386 | 0.050 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 2 | 2003 | 1731 | 0.050 |
Why?
|
| Attitude of Health Personnel | 1 | 2017 | 3922 | 0.050 |
Why?
|
| Bioterrorism | 1 | 2004 | 144 | 0.050 |
Why?
|
| Leadership | 2 | 2015 | 1395 | 0.050 |
Why?
|
| Gene Expression Profiling | 3 | 2014 | 9510 | 0.050 |
Why?
|
| Phosphorylation | 3 | 2013 | 8326 | 0.050 |
Why?
|
| Adipose Tissue | 1 | 2014 | 3334 | 0.050 |
Why?
|
| Drug Implants | 1 | 2003 | 230 | 0.050 |
Why?
|
| Neutrophils | 2 | 2014 | 3785 | 0.050 |
Why?
|
| Cyclopropanes | 1 | 2004 | 437 | 0.050 |
Why?
|
| Inflammation | 2 | 2019 | 10863 | 0.050 |
Why?
|
| Polymers | 4 | 2002 | 1630 | 0.050 |
Why?
|
| Cross Reactions | 3 | 1993 | 828 | 0.050 |
Why?
|
| Retrospective Studies | 5 | 2022 | 81801 | 0.050 |
Why?
|
| Autoimmune Diseases | 1 | 2014 | 2257 | 0.050 |
Why?
|
| Epitopes, T-Lymphocyte | 2 | 2005 | 827 | 0.050 |
Why?
|
| Kinetics | 3 | 2001 | 6333 | 0.050 |
Why?
|
| Electrophoresis, Gel, Pulsed-Field | 1 | 2011 | 142 | 0.050 |
Why?
|
| Glycosyltransferases | 1 | 2002 | 114 | 0.050 |
Why?
|
| Epitopes, B-Lymphocyte | 1 | 2002 | 85 | 0.050 |
Why?
|
| Surgical Wound Infection | 1 | 2011 | 1545 | 0.050 |
Why?
|
| Regression Analysis | 1 | 2011 | 6350 | 0.050 |
Why?
|
| Molecular Typing | 1 | 2011 | 115 | 0.050 |
Why?
|
| Phenols | 2 | 1998 | 520 | 0.050 |
Why?
|
| Acetyltransferases | 1 | 2002 | 231 | 0.050 |
Why?
|
| Nitric Oxide Synthase | 2 | 2001 | 911 | 0.050 |
Why?
|
| Schools, Medical | 1 | 2007 | 881 | 0.050 |
Why?
|
| Substrate Specificity | 3 | 2001 | 1753 | 0.050 |
Why?
|
| PPAR gamma | 1 | 2023 | 487 | 0.050 |
Why?
|
| Sensitivity and Specificity | 3 | 2014 | 14737 | 0.040 |
Why?
|
| Sequence Analysis, Protein | 1 | 2002 | 265 | 0.040 |
Why?
|
| Pregnancy | 1 | 2022 | 30200 | 0.040 |
Why?
|
| Intracellular Fluid | 1 | 2000 | 201 | 0.040 |
Why?
|
| Antigens, Surface | 2 | 2004 | 1616 | 0.040 |
Why?
|
| Escherichia coli | 6 | 2019 | 4211 | 0.040 |
Why?
|
| Interleukin-10 | 2 | 2017 | 1184 | 0.040 |
Why?
|
| I-kappa B Proteins | 1 | 2001 | 210 | 0.040 |
Why?
|
| Hemolysin Proteins | 1 | 2000 | 113 | 0.040 |
Why?
|
| Cross-Sectional Studies | 1 | 2021 | 26375 | 0.040 |
Why?
|
| Medically Underserved Area | 1 | 2022 | 266 | 0.040 |
Why?
|
| Basophil Degranulation Test | 1 | 2020 | 20 | 0.040 |
Why?
|
| HIV Infections | 2 | 2018 | 17575 | 0.040 |
Why?
|
| Dermatophagoides farinae | 1 | 2019 | 19 | 0.040 |
Why?
|
| Virulence | 3 | 2014 | 1298 | 0.040 |
Why?
|
| Interleukin-12 Subunit p35 | 1 | 2019 | 22 | 0.040 |
Why?
|
| alpha-Galactosidase | 1 | 2020 | 58 | 0.040 |
Why?
|
| Bipolar Disorder | 1 | 2017 | 5126 | 0.040 |
Why?
|
| Double-Blind Method | 1 | 2014 | 12456 | 0.040 |
Why?
|
| Forkhead Transcription Factors | 1 | 2007 | 1623 | 0.040 |
Why?
|
| Adolescent | 7 | 2017 | 89184 | 0.040 |
Why?
|
| Aged | 14 | 2017 | 171562 | 0.040 |
Why?
|
| Lipoproteins | 2 | 2007 | 880 | 0.040 |
Why?
|
| Pyrroles | 1 | 2006 | 1126 | 0.040 |
Why?
|
| Cell Lineage | 3 | 2013 | 2574 | 0.040 |
Why?
|
| Quality Indicators, Health Care | 1 | 2009 | 1813 | 0.040 |
Why?
|
| Caspase 8 | 1 | 2020 | 198 | 0.040 |
Why?
|
| Alcohol Oxidoreductases | 1 | 2000 | 164 | 0.040 |
Why?
|
| Antigens, Dermatophagoides | 1 | 2019 | 102 | 0.040 |
Why?
|
| Gene Deletion | 1 | 2007 | 2673 | 0.040 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2014 | 3440 | 0.040 |
Why?
|
| Quality Improvement | 1 | 2015 | 3858 | 0.040 |
Why?
|
| Vibrio cholerae | 1 | 2005 | 793 | 0.040 |
Why?
|
| Software | 1 | 2013 | 4453 | 0.040 |
Why?
|
| Genotype | 4 | 2017 | 13042 | 0.040 |
Why?
|
| Furans | 1 | 2000 | 201 | 0.040 |
Why?
|
| CDP-Diacylglycerol-Inositol 3-Phosphatidyltransferase | 1 | 1999 | 3 | 0.040 |
Why?
|
| Depressive Disorder, Major | 1 | 2017 | 4819 | 0.040 |
Why?
|
| Pulmonary Eosinophilia | 1 | 2019 | 78 | 0.040 |
Why?
|
| Caspase 1 | 1 | 2020 | 227 | 0.040 |
Why?
|
| Immunoglobulin G | 1 | 1991 | 4570 | 0.040 |
Why?
|
| United States | 6 | 2021 | 73150 | 0.040 |
Why?
|
| Diet | 1 | 2017 | 8090 | 0.040 |
Why?
|
| Dimerization | 1 | 2000 | 886 | 0.040 |
Why?
|
| Cations, Divalent | 1 | 1999 | 167 | 0.040 |
Why?
|
| Multienzyme Complexes | 1 | 2002 | 665 | 0.040 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2014 | 3777 | 0.040 |
Why?
|
| Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2010 | 1643 | 0.040 |
Why?
|
| Sugar Phosphates | 1 | 1998 | 44 | 0.040 |
Why?
|
| Hospitals, Teaching | 1 | 2023 | 1158 | 0.040 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 3 | 2013 | 3794 | 0.040 |
Why?
|
| Child | 3 | 2022 | 80891 | 0.040 |
Why?
|
| Protein Structure, Tertiary | 2 | 2006 | 3779 | 0.040 |
Why?
|
| Schizophrenia | 1 | 2017 | 6987 | 0.040 |
Why?
|
| Education, Medical, Undergraduate | 1 | 2007 | 1082 | 0.040 |
Why?
|
| Prodrugs | 1 | 2000 | 275 | 0.040 |
Why?
|
| Research Design | 1 | 2014 | 6210 | 0.040 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2001 | 637 | 0.040 |
Why?
|
| Peptides | 3 | 2006 | 4353 | 0.040 |
Why?
|
| Anti-Infective Agents | 1 | 2005 | 985 | 0.040 |
Why?
|
| Recombinant Proteins | 3 | 2003 | 6510 | 0.040 |
Why?
|
| Inositol | 1 | 1999 | 216 | 0.040 |
Why?
|
| Radioisotope Dilution Technique | 1 | 1997 | 71 | 0.040 |
Why?
|
| Cell Movement | 1 | 2010 | 5215 | 0.040 |
Why?
|
| Indoles | 1 | 2006 | 1825 | 0.040 |
Why?
|
| Disaster Planning | 1 | 2004 | 560 | 0.040 |
Why?
|
| Corynebacterium | 1 | 1997 | 49 | 0.040 |
Why?
|
| Pyruvates | 2 | 1995 | 83 | 0.040 |
Why?
|
| Bronchoalveolar Lavage Fluid | 1 | 2019 | 761 | 0.040 |
Why?
|
| Receptors, Immunologic | 2 | 2019 | 1416 | 0.040 |
Why?
|
| Cytosol | 1 | 2000 | 886 | 0.040 |
Why?
|
| Nuclear Transfer Techniques | 1 | 2017 | 61 | 0.040 |
Why?
|
| Typhoid Fever | 1 | 2019 | 195 | 0.040 |
Why?
|
| Lipopeptides | 1 | 1997 | 71 | 0.040 |
Why?
|
| Heat-Shock Proteins | 2 | 1992 | 797 | 0.030 |
Why?
|
| Trisaccharides | 2 | 1997 | 50 | 0.030 |
Why?
|
| Pentoses | 1 | 1996 | 7 | 0.030 |
Why?
|
| Tritium | 1 | 1997 | 707 | 0.030 |
Why?
|
| Glycosylation | 2 | 2002 | 1100 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2004 | 10776 | 0.030 |
Why?
|
| Autoantibodies | 1 | 2005 | 2126 | 0.030 |
Why?
|
| Models, Structural | 1 | 1997 | 340 | 0.030 |
Why?
|
| Interleukin-12 | 1 | 1999 | 577 | 0.030 |
Why?
|
| Sepsis | 1 | 2011 | 2601 | 0.030 |
Why?
|
| Young Adult | 4 | 2017 | 60049 | 0.030 |
Why?
|
| Bacteroides fragilis | 1 | 2018 | 250 | 0.030 |
Why?
|
| Amino Acids | 2 | 2013 | 1716 | 0.030 |
Why?
|
| Uridine Diphosphate N-Acetylglucosamine | 1 | 1996 | 18 | 0.030 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2006 | 2884 | 0.030 |
Why?
|
| Fibrosis | 1 | 2023 | 2077 | 0.030 |
Why?
|
| Epitopes | 3 | 1993 | 2525 | 0.030 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2003 | 4588 | 0.030 |
Why?
|
| Models, Molecular | 3 | 2013 | 5404 | 0.030 |
Why?
|
| Nuclear Receptor Subfamily 1, Group F, Member 3 | 1 | 2017 | 151 | 0.030 |
Why?
|
| Sulfonamides | 1 | 2006 | 1980 | 0.030 |
Why?
|
| Mentors | 2 | 2015 | 672 | 0.030 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2001 | 1246 | 0.030 |
Why?
|
| Urinalysis | 1 | 2018 | 369 | 0.030 |
Why?
|
| Laboratories, Hospital | 1 | 2017 | 192 | 0.030 |
Why?
|
| Chromatography, High Pressure Liquid | 2 | 2011 | 1539 | 0.030 |
Why?
|
| Lung | 3 | 2024 | 10089 | 0.030 |
Why?
|
| Isoenzymes | 1 | 2000 | 1684 | 0.030 |
Why?
|
| Early Growth Response Protein 2 | 1 | 2015 | 25 | 0.030 |
Why?
|
| Alkylation | 1 | 1995 | 84 | 0.030 |
Why?
|
| NF-kappa B | 2 | 2001 | 2489 | 0.030 |
Why?
|
| Protein Conformation | 3 | 2013 | 3955 | 0.030 |
Why?
|
| Deuterium | 1 | 1995 | 106 | 0.030 |
Why?
|
| Gene Regulatory Networks | 2 | 2014 | 1753 | 0.030 |
Why?
|
| Inflammasomes | 1 | 2020 | 540 | 0.030 |
Why?
|
| Flavonoids | 1 | 1998 | 447 | 0.030 |
Why?
|
| Patients' Rooms | 1 | 1995 | 62 | 0.030 |
Why?
|
| Galactose | 1 | 1996 | 299 | 0.030 |
Why?
|
| Epithelial Cells | 1 | 2006 | 3695 | 0.030 |
Why?
|
| Specific Pathogen-Free Organisms | 1 | 2014 | 220 | 0.030 |
Why?
|
| DNA Fingerprinting | 2 | 2009 | 114 | 0.030 |
Why?
|
| T-Box Domain Proteins | 1 | 2017 | 473 | 0.030 |
Why?
|
| Internship and Residency | 1 | 2015 | 5949 | 0.030 |
Why?
|
| Ligands | 2 | 2019 | 3283 | 0.030 |
Why?
|
| Monocytes | 2 | 2005 | 2595 | 0.030 |
Why?
|
| Basic-Leucine Zipper Transcription Factors | 1 | 2014 | 153 | 0.030 |
Why?
|
| Access to Information | 1 | 2017 | 317 | 0.030 |
Why?
|
| Phylogeny | 2 | 2019 | 2843 | 0.030 |
Why?
|
| Antigen-Presenting Cells | 2 | 1995 | 962 | 0.030 |
Why?
|
| Cell Growth Processes | 1 | 2014 | 381 | 0.030 |
Why?
|
| Cohort Studies | 4 | 2023 | 41795 | 0.030 |
Why?
|
| Molecular Weight | 2 | 1997 | 2172 | 0.030 |
Why?
|
| Mycobacterium chelonae | 1 | 1993 | 12 | 0.030 |
Why?
|
| Isomerism | 1 | 1993 | 198 | 0.030 |
Why?
|
| Hybridomas | 2 | 1992 | 444 | 0.030 |
Why?
|
| Perforin | 1 | 2014 | 167 | 0.030 |
Why?
|
| Glycosides | 1 | 1993 | 100 | 0.030 |
Why?
|
| Clarithromycin | 1 | 1993 | 87 | 0.030 |
Why?
|
| Antibodies, Bacterial | 3 | 2006 | 1478 | 0.030 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2002 | 3731 | 0.030 |
Why?
|
| Structure-Activity Relationship | 3 | 2007 | 3055 | 0.030 |
Why?
|
| RNA | 1 | 2023 | 2726 | 0.030 |
Why?
|
| Antineoplastic Agents | 1 | 2016 | 13697 | 0.030 |
Why?
|
| Receptors, Virus | 1 | 1996 | 648 | 0.030 |
Why?
|
| Enzyme Activation | 1 | 1999 | 3587 | 0.030 |
Why?
|
| Pyruvic Acid | 1 | 1994 | 205 | 0.030 |
Why?
|
| Transplantation Immunology | 1 | 1995 | 538 | 0.030 |
Why?
|
| Statistics as Topic | 1 | 1999 | 2363 | 0.030 |
Why?
|
| Isoelectric Point | 1 | 2012 | 76 | 0.030 |
Why?
|
| Hydrolysis | 1 | 1993 | 646 | 0.030 |
Why?
|
| Practice Guidelines as Topic | 1 | 2010 | 7453 | 0.030 |
Why?
|
| Algorithms | 1 | 2013 | 14154 | 0.030 |
Why?
|
| Organ Specificity | 1 | 2017 | 1967 | 0.030 |
Why?
|
| Methylation | 1 | 1995 | 1076 | 0.020 |
Why?
|
| Feces | 1 | 2019 | 1512 | 0.020 |
Why?
|
| Succinates | 1 | 2012 | 83 | 0.020 |
Why?
|
| Nitric Oxide | 1 | 2001 | 2144 | 0.020 |
Why?
|
| Histocompatibility Antigens | 1 | 2013 | 478 | 0.020 |
Why?
|
| Aged, 80 and over | 4 | 2011 | 59686 | 0.020 |
Why?
|
| Sequence Alignment | 3 | 2002 | 2176 | 0.020 |
Why?
|
| Risk Factors | 6 | 2011 | 74962 | 0.020 |
Why?
|
| Immune Sera | 1 | 1991 | 605 | 0.020 |
Why?
|
| Interleukin-17 | 1 | 2017 | 923 | 0.020 |
Why?
|
| Genome, Bacterial | 2 | 2006 | 796 | 0.020 |
Why?
|
| Protein Binding | 2 | 2014 | 9343 | 0.020 |
Why?
|
| Receptors, Antigen, T-Cell, gamma-delta | 1 | 2013 | 354 | 0.020 |
Why?
|
| Immunization | 1 | 1995 | 1219 | 0.020 |
Why?
|
| Purchasing, Hospital | 1 | 2010 | 14 | 0.020 |
Why?
|
| Coculture Techniques | 1 | 2014 | 1342 | 0.020 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2013 | 450 | 0.020 |
Why?
|
| Genes, T-Cell Receptor alpha | 1 | 2009 | 19 | 0.020 |
Why?
|
| Drosophila Proteins | 1 | 1999 | 1712 | 0.020 |
Why?
|
| Receptors, Cell Surface | 1 | 1999 | 2819 | 0.020 |
Why?
|
| Genes, T-Cell Receptor beta | 1 | 2009 | 70 | 0.020 |
Why?
|
| Immunity, Cellular | 2 | 1995 | 1561 | 0.020 |
Why?
|
| Microarray Analysis | 1 | 2012 | 753 | 0.020 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2006 | 5708 | 0.020 |
Why?
|
| Philippines | 1 | 2009 | 95 | 0.020 |
Why?
|
| Organizational Case Studies | 1 | 2010 | 301 | 0.020 |
Why?
|
| Repressor Proteins | 2 | 2013 | 2986 | 0.020 |
Why?
|
| Autoradiography | 2 | 2002 | 732 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2011 | 24318 | 0.020 |
Why?
|
| Forms and Records Control | 1 | 2009 | 158 | 0.020 |
Why?
|
| Health Personnel | 1 | 2023 | 3380 | 0.020 |
Why?
|
| Phagocytosis | 1 | 2014 | 1530 | 0.020 |
Why?
|
| Multifactorial Inheritance | 1 | 2017 | 1421 | 0.020 |
Why?
|
| Nitric Oxide Synthase Type II | 2 | 2001 | 515 | 0.020 |
Why?
|
| Minisatellite Repeats | 1 | 2009 | 164 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2010 | 474 | 0.020 |
Why?
|
| Membrane Glycoproteins | 1 | 1999 | 3712 | 0.020 |
Why?
|
| Phosphates | 1 | 2012 | 765 | 0.020 |
Why?
|
| Mice, Nude | 1 | 2014 | 3632 | 0.020 |
Why?
|
| Reproducibility of Results | 2 | 2018 | 20224 | 0.020 |
Why?
|
| Curriculum | 2 | 2015 | 3776 | 0.020 |
Why?
|
| Physician's Role | 1 | 2015 | 926 | 0.020 |
Why?
|
| Carrier Proteins | 1 | 2001 | 4936 | 0.020 |
Why?
|
| Saccharomyces cerevisiae | 1 | 1999 | 2676 | 0.020 |
Why?
|
| Receptors, IgG | 1 | 1991 | 564 | 0.020 |
Why?
|
| DNA Primers | 2 | 2002 | 2825 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2023 | 12805 | 0.020 |
Why?
|
| Tumor Burden | 1 | 2014 | 1913 | 0.020 |
Why?
|
| Adaptive Immunity | 1 | 2012 | 731 | 0.020 |
Why?
|
| Patient Admission | 1 | 1995 | 1367 | 0.020 |
Why?
|
| Protein Isoforms | 1 | 2012 | 1703 | 0.020 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2019 | 3407 | 0.020 |
Why?
|
| Cytoplasm | 1 | 1992 | 1502 | 0.020 |
Why?
|
| Molecular Epidemiology | 1 | 2009 | 473 | 0.020 |
Why?
|
| Tuberculin | 1 | 2006 | 64 | 0.020 |
Why?
|
| Repetitive Sequences, Amino Acid | 1 | 2006 | 91 | 0.020 |
Why?
|
| Cytotoxins | 1 | 2007 | 154 | 0.020 |
Why?
|
| Cell Fractionation | 1 | 2006 | 247 | 0.020 |
Why?
|
| Genome-Wide Association Study | 2 | 2017 | 12778 | 0.020 |
Why?
|
| Chimera | 1 | 2007 | 454 | 0.020 |
Why?
|
| Chromosome Mapping | 1 | 2014 | 4622 | 0.020 |
Why?
|
| Antigens, Neoplasm | 1 | 2014 | 1999 | 0.020 |
Why?
|
| Phenotype | 3 | 2014 | 16721 | 0.020 |
Why?
|
| Mycobacterium marinum | 1 | 2005 | 29 | 0.020 |
Why?
|
| Healthcare Disparities | 1 | 2021 | 3413 | 0.020 |
Why?
|
| Mice, Inbred NOD | 1 | 2010 | 1839 | 0.020 |
Why?
|
| Inpatients | 1 | 2017 | 2570 | 0.020 |
Why?
|
| Base Sequence | 3 | 2002 | 12422 | 0.020 |
Why?
|
| Open Reading Frames | 2 | 2000 | 812 | 0.020 |
Why?
|
| Predictive Value of Tests | 2 | 2018 | 15455 | 0.020 |
Why?
|
| Receptors, Interleukin-2 | 2 | 2003 | 564 | 0.020 |
Why?
|
| Rabbits | 1 | 1991 | 4781 | 0.020 |
Why?
|
| Mice, SCID | 1 | 2010 | 2632 | 0.010 |
Why?
|
| Case-Control Studies | 2 | 2017 | 22296 | 0.010 |
Why?
|
| Comorbidity | 1 | 1999 | 10588 | 0.010 |
Why?
|
| Nuclear Magnetic Resonance, Biomolecular | 1 | 2007 | 508 | 0.010 |
Why?
|
| Mice, Mutant Strains | 1 | 2007 | 1755 | 0.010 |
Why?
|
| Thiophenes | 2 | 2000 | 569 | 0.010 |
Why?
|
| Cost-Benefit Analysis | 1 | 2017 | 5538 | 0.010 |
Why?
|
| Medical Records | 1 | 2009 | 1412 | 0.010 |
Why?
|
| Receptors, Antigen | 1 | 2004 | 51 | 0.010 |
Why?
|
| Serologic Tests | 2 | 2000 | 383 | 0.010 |
Why?
|
| Apoptosis | 1 | 2020 | 9516 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2017 | 18048 | 0.010 |
Why?
|
| Diagnostic Techniques and Procedures | 1 | 2005 | 219 | 0.010 |
Why?
|
| Glucose | 1 | 1995 | 4352 | 0.010 |
Why?
|
| Homeostasis | 1 | 2014 | 3349 | 0.010 |
Why?
|
| Spleen | 1 | 2009 | 2296 | 0.010 |
Why?
|
| Trans-Activators | 1 | 2013 | 2856 | 0.010 |
Why?
|
| Carbon Isotopes | 1 | 2004 | 458 | 0.010 |
Why?
|
| Liver | 1 | 1999 | 7574 | 0.010 |
Why?
|
| Esters | 1 | 2004 | 212 | 0.010 |
Why?
|
| Lymphocyte Count | 1 | 2005 | 793 | 0.010 |
Why?
|
| Conflict of Interest | 1 | 2007 | 555 | 0.010 |
Why?
|
| Health Care Costs | 1 | 2016 | 3267 | 0.010 |
Why?
|
| Serine | 2 | 1997 | 831 | 0.010 |
Why?
|
| Rats | 1 | 1999 | 23835 | 0.010 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2014 | 16028 | 0.010 |
Why?
|
| Diagnostic Errors | 1 | 2009 | 1280 | 0.010 |
Why?
|
| Conserved Sequence | 1 | 2005 | 1163 | 0.010 |
Why?
|
| Cell Culture Techniques | 1 | 2009 | 1667 | 0.010 |
Why?
|
| Membrane Proteins | 1 | 2019 | 7880 | 0.010 |
Why?
|
| Acyl-Carrier Protein S-Malonyltransferase | 1 | 2001 | 2 | 0.010 |
Why?
|
| Arginine | 1 | 2005 | 923 | 0.010 |
Why?
|
| Time Factors | 1 | 2003 | 40272 | 0.010 |
Why?
|
| Emergency Service, Hospital | 1 | 2021 | 7955 | 0.010 |
Why?
|
| MAP Kinase Kinase 7 | 1 | 2001 | 14 | 0.010 |
Why?
|
| Interprofessional Relations | 1 | 2007 | 997 | 0.010 |
Why?
|
| Prevalence | 1 | 1998 | 15872 | 0.010 |
Why?
|
| Amoxicillin | 1 | 2002 | 182 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2011 | 26411 | 0.010 |
Why?
|
| Urban Population | 1 | 2009 | 2045 | 0.010 |
Why?
|
| Drug Industry | 1 | 2007 | 793 | 0.010 |
Why?
|
| Amino Acid Substitution | 1 | 2005 | 1742 | 0.010 |
Why?
|
| Epidermis | 1 | 2004 | 539 | 0.010 |
Why?
|
| Gene Expression | 1 | 2014 | 7598 | 0.010 |
Why?
|
| DNA-Binding Proteins | 2 | 2013 | 9614 | 0.010 |
Why?
|
| Lysine | 1 | 2005 | 988 | 0.010 |
Why?
|
| Length of Stay | 1 | 1995 | 6519 | 0.010 |
Why?
|
| Multiprotein Complexes | 1 | 2007 | 1110 | 0.010 |
Why?
|
| Syndrome | 1 | 2007 | 3275 | 0.010 |
Why?
|
| Asthma | 1 | 2019 | 6280 | 0.010 |
Why?
|
| Enzyme Induction | 1 | 2001 | 455 | 0.010 |
Why?
|
| Biotransformation | 1 | 2000 | 166 | 0.010 |
Why?
|
| Patient Readmission | 1 | 1995 | 3312 | 0.010 |
Why?
|
| Treatment Outcome | 2 | 2016 | 65379 | 0.010 |
Why?
|
| Genetic Complementation Test | 1 | 2001 | 557 | 0.010 |
Why?
|
| Postoperative Complications | 1 | 2003 | 15881 | 0.010 |
Why?
|
| CD4 Lymphocyte Count | 1 | 2006 | 2596 | 0.010 |
Why?
|
| Hexosamines | 1 | 1999 | 38 | 0.010 |
Why?
|
| Lipids | 2 | 2005 | 3344 | 0.010 |
Why?
|
| Bone Marrow Cells | 1 | 2007 | 2414 | 0.010 |
Why?
|
| Academic Medical Centers | 1 | 2010 | 2783 | 0.010 |
Why?
|
| Genomic Library | 1 | 1999 | 188 | 0.010 |
Why?
|
| Sex Factors | 1 | 2013 | 10654 | 0.010 |
Why?
|
| Genome, Human | 1 | 2012 | 4450 | 0.010 |
Why?
|
| MAP Kinase Kinase 1 | 1 | 2001 | 331 | 0.010 |
Why?
|
| Penicillins | 1 | 2002 | 406 | 0.010 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 1 | 2001 | 440 | 0.010 |
Why?
|
| Faculty, Medical | 1 | 2007 | 1218 | 0.010 |
Why?
|
| MicroRNAs | 1 | 2015 | 3804 | 0.010 |
Why?
|
| Rural Population | 1 | 2009 | 2318 | 0.010 |
Why?
|
| Coronary Angiography | 1 | 2010 | 4537 | 0.010 |
Why?
|
| Oxidoreductases | 1 | 2000 | 412 | 0.010 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2001 | 1682 | 0.010 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2001 | 692 | 0.010 |
Why?
|
| Cord Factors | 1 | 1997 | 6 | 0.010 |
Why?
|
| Mutagenesis, Insertional | 1 | 2000 | 662 | 0.010 |
Why?
|
| Esterification | 1 | 1997 | 39 | 0.010 |
Why?
|
| Peptide Fragments | 1 | 1990 | 5151 | 0.010 |
Why?
|
| Base Composition | 1 | 1997 | 291 | 0.010 |
Why?
|
| Interleukin-6 | 1 | 2007 | 3230 | 0.010 |
Why?
|
| Biopsy | 1 | 2009 | 6808 | 0.010 |
Why?
|
| Indicators and Reagents | 1 | 1998 | 455 | 0.010 |
Why?
|
| Palmitates | 1 | 1997 | 70 | 0.010 |
Why?
|
| Disaccharides | 1 | 1997 | 170 | 0.010 |
Why?
|
| Azides | 1 | 1997 | 120 | 0.010 |
Why?
|
| Fetal Blood | 1 | 2004 | 1361 | 0.010 |
Why?
|
| Glycoside Hydrolases | 1 | 1997 | 135 | 0.010 |
Why?
|
| Immunoblotting | 1 | 2000 | 1647 | 0.010 |
Why?
|
| Microscopy, Fluorescence | 1 | 2004 | 2636 | 0.010 |
Why?
|
| Age Factors | 1 | 2013 | 18471 | 0.010 |
Why?
|
| Palmitic Acid | 1 | 1997 | 149 | 0.010 |
Why?
|
| Isotope Labeling | 1 | 1998 | 395 | 0.010 |
Why?
|
| Polymorphism, Restriction Fragment Length | 1 | 1997 | 767 | 0.010 |
Why?
|
| Cell Division | 1 | 2004 | 4479 | 0.010 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 1997 | 1056 | 0.010 |
Why?
|
| Restriction Mapping | 1 | 1996 | 849 | 0.010 |
Why?
|
| Plasmids | 1 | 2001 | 2268 | 0.010 |
Why?
|
| Nucleic Acid Hybridization | 1 | 1997 | 1305 | 0.010 |
Why?
|
| Toll-Like Receptors | 1 | 1999 | 582 | 0.010 |
Why?
|
| Sequence Analysis, DNA | 1 | 2006 | 4775 | 0.010 |
Why?
|
| Biopolymers | 1 | 1996 | 183 | 0.010 |
Why?
|
| Crohn Disease | 1 | 1988 | 2293 | 0.010 |
Why?
|
| Skin | 1 | 2009 | 4499 | 0.010 |
Why?
|
| Culture Media | 1 | 1997 | 898 | 0.010 |
Why?
|
| Polyisoprenyl Phosphate Monosaccharides | 1 | 1994 | 3 | 0.010 |
Why?
|
| Selection, Genetic | 1 | 1999 | 877 | 0.010 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 1996 | 505 | 0.010 |
Why?
|
| Quality Assurance, Health Care | 1 | 2005 | 2181 | 0.010 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 2007 | 2257 | 0.010 |
Why?
|
| Temperature | 1 | 2001 | 2235 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2014 | 18362 | 0.010 |
Why?
|
| Escherichia coli Proteins | 1 | 2001 | 1057 | 0.010 |
Why?
|
| Physician-Patient Relations | 1 | 2007 | 3267 | 0.010 |
Why?
|
| Culture Media, Conditioned | 1 | 1995 | 521 | 0.010 |
Why?
|
| DNA Transposable Elements | 1 | 1997 | 762 | 0.010 |
Why?
|
| India | 1 | 2000 | 2325 | 0.010 |
Why?
|
| Transcription Factors | 1 | 2013 | 12166 | 0.010 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 1997 | 1050 | 0.010 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 1997 | 2488 | 0.010 |
Why?
|
| Telemedicine | 1 | 2010 | 3107 | 0.010 |
Why?
|
| BCG Vaccine | 1 | 1995 | 383 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 1999 | 6132 | 0.010 |
Why?
|
| Clinical Trials as Topic | 1 | 2007 | 8051 | 0.010 |
Why?
|
| Transfection | 1 | 1999 | 5764 | 0.010 |
Why?
|
| Genetic Markers | 1 | 1997 | 2604 | 0.010 |
Why?
|
| Histoplasmosis | 1 | 1990 | 63 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2007 | 17135 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2004 | 11120 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2003 | 12092 | 0.010 |
Why?
|
| Evaluation Studies as Topic | 1 | 1990 | 1629 | 0.000 |
Why?
|
| Lipid A | 1 | 1988 | 70 | 0.000 |
Why?
|
| False Positive Reactions | 1 | 1990 | 962 | 0.000 |
Why?
|
| Immunocompromised Host | 1 | 1993 | 863 | 0.000 |
Why?
|
| Glioma | 1 | 2003 | 3526 | 0.000 |
Why?
|
| Neoplasms | 1 | 2016 | 22385 | 0.000 |
Why?
|
| Immunoglobulins | 1 | 1988 | 855 | 0.000 |
Why?
|
| Mice, Inbred C3H | 1 | 1985 | 915 | 0.000 |
Why?
|
| Binding, Competitive | 1 | 1985 | 1142 | 0.000 |
Why?
|
| Interleukin-1 | 1 | 1985 | 1251 | 0.000 |
Why?
|
| Mutation | 1 | 2001 | 30228 | 0.000 |
Why?
|